Imperial College London
Portrait Picture

ProfessorIainMcNeish

Faculty of Medicine, Department of Surgery & Cancer

Chair in Oncology
 
 
 
//

Contact

 

+44 (0)20 7594 2185i.mcneish Website

 
 
//

Assistant

 

Ms Sophie Lions +44 (0)20 7594 2792

 
//

Location

 

G036Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Glasspool:2017:10.1200/JCO.2017.35.15_suppl.2594,
author = {Glasspool, RM and Blagden, SP and Lockley, M and Paul, J and Hopkins, C and Thomson, F and Brown, J and Fernandes, R and Douglas, N and Pou, C and Hanif, A and Campbell, C and Multani, PS and Tucker, T and McNeish, LA and Evans, TRJ},
doi = {10.1200/JCO.2017.35.15_suppl.2594},
publisher = {AMER SOC CLINICAL ONCOLOGY},
title = {A phase I trial of the oral hedgehog inhibitor taladegib (LY2940680) in combination with weekly paclitaxel in patients with advanced, solid tumours.},
url = {http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.2594},
year = {2017}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Glasspool,RM
AU  - Blagden,SP
AU  - Lockley,M
AU  - Paul,J
AU  - Hopkins,C
AU  - Thomson,F
AU  - Brown,J
AU  - Fernandes,R
AU  - Douglas,N
AU  - Pou,C
AU  - Hanif,A
AU  - Campbell,C
AU  - Multani,PS
AU  - Tucker,T
AU  - McNeish,LA
AU  - Evans,TRJ
DO  - 10.1200/JCO.2017.35.15_suppl.2594
PB  - AMER SOC CLINICAL ONCOLOGY
PY  - 2017///
SN  - 0732-183X
TI  - A phase I trial of the oral hedgehog inhibitor taladegib (LY2940680) in combination with weekly paclitaxel in patients with advanced, solid tumours.
UR  - http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.2594
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411895705012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download